39 filings
8-K
RLAY
Relay Therapeutics Inc
6 Jun 24
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
8:00am
8-K
RLAY
Relay Therapeutics Inc
3 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
RLAY
Relay Therapeutics Inc
2 May 24
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
4:10pm
8-K
RLAY
Relay Therapeutics Inc
22 Feb 24
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:10pm
8-K
RLAY
Relay Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
8-K
pcjx6h
2 Nov 23
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
e0lueobdk3g08i529
12 Oct 23
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
4:13pm
8-K
q1iexm9 jtetm
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
8-K
pyeelfmuf7r9vteq
31 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
yeix05qenb
25 May 23
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
5:05pm
8-K
u7qujdyllb1y1 yfvu
4 May 23
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
b7s5naqhvypipomk1
18 Apr 23
Regulation FD Disclosure
10:42am
8-K
9ucjojx
23 Feb 23
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
4:11pm
8-K
cae0mihu3
9 Jan 23
JPM Presentation January 2023
7:01am
8-K
6nu2c6orcbj7dohg
3 Nov 22
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:11pm
8-K
zoyef pvuqjtmsk7ci4d
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
8-K
9yic zd7i137
12 Sep 22
Enrollment for the pivotal cohort anticipated to be completed in the second half of 2023
6:05am
8-K
7d1oiqx539l pos8z
8 Sep 22
Regulation FD Disclosure
6:31am
8-K
r3hn9zue2n
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
hmqy85
27 Jul 22
Departure of Directors or Certain Officers
8:01am